KLA Corporation
KLAC
$165.74
-5.00%
KLA Corporation is one of the world's largest semiconductor wafer fabrication equipment (WFE) manufacturers, specializing in process control — inspection and metrology systems that detect defects and verify precise measurements on wafers during both R&D and high-volume manufacturing — while also holding smaller positions in etch/deposition and PCB/component inspection. Its competitive identity is that of a dominant niche monopolist: KLA holds a majority share of the process control segment and counts TSMC and Samsung among its largest customers, giving it pricing power and margins that are the envy of the broader equipment sector. The current investor narrative is a tug-of-war between the structural AI-driven capex boom — reinforced by headlines such as Tesla's Terafab project catalyzing a broad semiconductor supply-chain buildout and billionaire investors adding chip-equipment names — and a sharp late-2026 de-rating in the shares, which have fallen roughly 46% from their June peak despite a 15% YoY revenue growth print and a ten-for-one stock split announced in May 2026 to broaden the investor base. Bulls point to KLA's 61% gross margin, 42% operating margin, and mission-critical position in advanced-node inspection as durable moats; bears worry that the stock's extreme valuation multiples and a decelerating order environment leave little room for error.…
KLAC
KLA Corporation
$165.74
Related headlines
Investment Opinion: Should I buy KLAC Today?
Rating: Hold. The core thesis is that KLA's process-control monopoly and elite margins (61.36% gross, 42.49% operating) justify a premium, but the stock's 46% decline from its June high and -24.79 three-month relative underperformance signal that the market is repricing the WFE cycle; with the price below the lowest analyst target of $175 and a consensus Buy rating (mean 1.83) with a $232.77 average target, the risk-reward is balanced rather than compelling. The 40.4% upside to the average target is offset by the stock trading at the top of its historical valuation band on trailing metrics.
Supporting evidence: revenue grew 15.21% YoY to $3.658 billion in the June quarter, with a service annuity of $1.60 billion providing recurring stability. Profitability is elite, with net margin of 35.57% and ROE of 76.08%, while TTM FCF of $3.77 billion supports buybacks ($571 million in the June quarter). However, the trailing PE of 81.99x, PS of 29.14x, and EV/EBITDA of 66.10x are stretched versus the broader sector, and the 0.95% FCF yield offers little valuation support. The forward PE of 24.59x is more reasonable but relies on consensus EPS of $10.15, which may be at risk if the cycle decelerates.
Biggest risks: a WFE cycle downturn that cuts estimates and compresses the multiple, competitive encroachment in process control, and customer concentration in TSMC and Samsung. The rating would upgrade to Buy if the stock stabilizes above the $165-$168 congestion zone and forward estimates hold, or if the forward PE compresses below 20x on sustained order growth. It would downgrade to Sell if revenue growth decelerates below 10% or if the stock breaks below the $150s, opening a path to the $107.20 52-week low. Verdict: fairly valued to slightly overvalued on trailing metrics, but reasonably valued on forward earnings if the AI capex cycle persists.
Sign up to view all
KLAC 12-Month Price Forecast
The forward-looking view is balanced: KLA's fundamental quality is high, with 61% gross margins, 42% operating margins, and a process-control monopoly, but the stock is in a confirmed downtrend and trading at the top of its historical valuation band on trailing metrics. The forward PE of 24.59x provides a more reasonable anchor, and the price below the lowest analyst target suggests the selloff may be overdone, but the -24.79 three-month relative underperformance and 46% decline from the June high signal institutional distribution that could persist. The base case (50% probability) targets $200-$250 as the stock re-rates toward the average target, while the bear case (25%) targets $107-$175 if the WFE cycle turns. I would upgrade to bullish if the stock reclaims the $200 level and order growth accelerates, and downgrade to bearish if it breaks below the $150s or forward estimates are cut.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on KLA Corporation's 12-month outlook, with a consensus price target around $232.77 and implied upside of +40.4% versus the current price.
Average Target
$232.77
0 analysts
Implied Upside
+40.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$175 - $325
Analyst target range
Coverage is robust with 26 analysts, and the consensus recommendation is a Buy (mean rating of 1.83 on a 1–5 scale), with an average target price of $232.77 — implying roughly +40.4% upside from the current $165.74. The consensus leans bullish, but the distribution of recent ratings is more mixed than the headline suggests: of the ten most recent actions, four are Buy/Overweight (Jefferies, Stifel, Wells Fargo, Cantor Fitzgerald), four are Neutral/Hold (UBS, Deutsche Bank, Susquehanna, RBC), and two are Overweight (JP Morgan, Needham) — a split that reflects genuine debate about whether the AI capex cycle can sustain KLA's premium multiple.
The target range of $175 to $325 is wide, spanning a 46% spread from low to high and signaling high uncertainty: the high target of $325 assumes multiple expansion and a renewed AI-driven order surge that pushes EPS toward the high end of the $9.11–$11.42 estimate range, while the low target of $175 — only 5.6% above the current price — prices in margin compression and a cyclical downturn in WFE spending. Notably, the current price of $165.74 has fallen below even the lowest analyst target, a rare dislocation that suggests either the selloff is overdone or estimates are about to be cut; with consensus revenue of $31.77 billion and EPS of $10.15, the stock now trades at just 16.3x forward earnings, well below the 24.6x forward PE implied by the data, creating a potential value setup if the cycle holds.
Drowning in data?
Find the real signal!
Bulls vs Bears: KLAC Investment Factors
The bear case currently has stronger near-term evidence: the stock is in a confirmed downtrend with severe relative underperformance (-24.79 vs. SPY over three months), trading below the lowest analyst target, and sitting at the top of its historical valuation band on trailing metrics. However, the bull case rests on more durable fundamentals: a process-control monopoly with 61% gross margins, 15% revenue growth, a $1.6 billion service annuity, and a forward PE of 24.6x that is far less demanding than trailing multiples suggest. The single most important tension is whether the AI-driven WFE cycle has peaked or is merely pausing; if orders re-accelerate, the forward valuation provides a credible floor, but if the cycle rolls over, the trailing multiples and 0.95% FCF yield offer little support. The stock's 46% decline from its June high has partially de-risked the valuation, but the velocity of the selloff and the -45.07% max drawdown argue against calling a bottom prematurely.
Bullish
- Process control monopoly with elite margins: KLA holds a majority share of the semiconductor process control market, enabling gross margins of 61.36% and operating margins of 42.49% in the June 2026 quarter. These margins are essentially flat versus the year-ago quarter's 61.97% gross and 42.58% operating margins, demonstrating durable pricing power even as the cycle matures.
- Consensus Buy with 40% upside to target: 26 analysts rate KLAC a Buy (mean rating 1.83) with an average target price of $232.77, implying 40.4% upside from the current $165.74. The current price has fallen below even the lowest analyst target of $175, a rare dislocation that suggests the selloff may be overdone.
- Revenue growth still solid at 15% YoY: June 2026 revenue of $3.658 billion grew 15.21% year-over-year, with sequential growth of roughly 7% per quarter from $3.415 billion in March and $3.297 billion in December. The service segment contributes $1.60 billion in recurring revenue, providing a stabilizing annuity that cushions cyclical equipment orders.
- Forward valuation reasonable at 24.6x: While the trailing PE of 81.99x appears extreme, the forward PE of 24.59x based on consensus FY EPS of $10.15 is far more reasonable for a high-quality franchise. At the current price, the stock trades at just 16.3x forward earnings, well below the 24.6x implied by the data, creating a potential value setup if estimates hold.
Bearish
- Severe momentum breakdown and institutional distribution: KLAC has fallen 22.10% over three months and 46% from its June high of $307.37, with a -24.79 relative-strength reading versus the S&P 500's +2.69% over the quarter. The stock dropped 5.00% on the most recent session alone on volume of 13.1 million shares, signaling active institutional selling rather than a temporary pullback.
- Extreme trailing valuation multiples: The trailing PE of 81.99x, PS ratio of 29.14x, EV/EBITDA of 66.10x, and PB ratio of 62.32x are multiples typically reserved for hyper-growth software, not capital equipment. The PEG ratio of 3.99 and FCF yield of roughly 0.95% (TTM FCF of $3.77 billion against a $395.7 billion market cap) leave little margin of safety.
- Valuation at top of multi-year band: The PE ratio has expanded from 24.58x in June 2025 to 81.99x now, and the PS ratio has climbed from 37.25x to 108.19x over the same period, placing the stock at the very top of its own multi-year valuation band. A reversion toward the 25-35x PE range seen through 2024-2025 would imply substantial downside.
- Decelerating growth and WFE cycle peak fears: Revenue growth of 15.21% YoY, while healthy, represents a deceleration from prior-year comparisons, and the stock's 22% three-month decline suggests the market is already discounting a peak in the WFE cycle. The EBITDA margin dipped to 32.71% in the June quarter from 46.45% in March, partly due to a $196.8 million depreciation/amortization swing.
KLAC Technical Analysis
KLA is in a confirmed intermediate downtrend within a longer-term uptrend: the stock is up 50.84% over the past year but has fallen 22.10% over three months and 7.48% over six months, and at $165.74 it sits just 53.9% of the way up its 52-week range of $107.20–$307.37 — a dramatic collapse from the June high of $307.37 that has erased roughly 46% of peak value. The 1-year gain is now almost entirely front-loaded; the price is only 54.6% above its 52-week low, meaning the stock has given back the majority of its 2026 advance and is testing territory last seen in the spring. This positioning signals momentum breakdown rather than overextension — the stock is no longer near highs, but the velocity of the decline argues against calling it a clean value opportunity yet.
Short-term momentum is decisively negative and accelerating to the downside: the stock fell 5.00% on the most recent session alone (from $174.46 to $165.74) and is down 0.97% over the past month, a stark divergence from the +50.84% one-year trend and a -2.19 relative-strength reading versus the S&P 500's +1.22% monthly gain. The three-month relative strength of -24.79 versus SPY's +2.69% shows KLA is underperforming the market by nearly 25 percentage points over the quarter — a severe momentum divergence that typically signals institutional distribution rather than a temporary pullback. Volume of 13.1 million shares on the latest down day, combined with a short ratio of 2.58, suggests active selling pressure; the 1-month change (-0.97%) masking a brutal October slide from $206.89 on October 2 to $165.74 on October 16 (-19.9% in two weeks) confirms the trend is down, not merely consolidating.
Key technical levels are now clearly defined: support sits at the 52-week low of $107.20, roughly 35% below the current price, while resistance is the 52-week high of $307.37, an 85% gap above — a remarkably wide trading band that reflects the stock's extreme volatility. A breakdown below the recent $165–$168 congestion zone (the September 14–17 lows of $167.36–$169.09) would open the door to a retest of the $150s and potentially the $107 low, while any recovery would first need to reclaim the $200 psychological level and the October 2 high of $206.89. With a beta of 1.447, KLA is roughly 45% more volatile than the S&P 500, meaning position sizing should be materially smaller than a market-weight allocation; the max drawdown of -45.07% over the period underscores that this is a high-beta, high-dispersion name where stop discipline is essential.
Beta
1.45
1.45x market volatility
Max Drawdown
-45.1%
Largest decline past year
52-Week Range
$107-$307
Price range past year
Annual Return
+50.8%
Cumulative gain past year
| Period | KLAC Return | S&P 500 |
|---|---|---|
| 1m | -1.0% | +0.2% |
| 3m | -22.1% | +2.9% |
| 6m | -7.5% | +8.4% |
| 1y | +50.8% | +14.9% |
| ytd | +30.0% | +11.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
KLAC Fundamental Analysis
Revenue is growing at a healthy but decelerating clip: the most recent quarter (June 2026) delivered $3.658 billion in revenue, up 15.21% year-over-year, versus $3.415 billion in the March quarter and $3.297 billion in December — a sequential cadence of roughly 7% per quarter that annualizes to strong double-digit growth. The segment mix shows Defect Inspection as the largest contributor at $3.52 billion, followed by Service at $1.60 billion and Patterning at $1.34 billion, with PCB/Component Inspection ($263 million) and Specialty Semiconductor Process ($281 million) as smaller drags; the service annuity is a key stabilizer, providing recurring revenue that cushions cyclical equipment orders. The growth trend implies the AI capex cycle is still feeding demand for process control, but the deceleration from prior-year comparisons and the stock's 22% three-month decline suggest the market is already discounting a peak in the WFE cycle.
Profitability is exceptional and stable at the high end of the industry: net income was $1.363 billion in the June quarter on a 37.27% net margin, with gross margin at 61.36% and operating margin at 42.49% — margins that are essentially flat to slightly expanding versus the year-ago quarter's 61.97% gross and 42.58% operating margins. The EBITDA margin of 32.71% in the latest quarter dipped from 46.45% in the March quarter, largely due to a $196.8 million depreciation/amortization swing and a lower other-income line, but the core operating profitability remains elite for a capital-equipment manufacturer. With EPS of $1.04 in the quarter and a trailing PE of 81.99x, the company is clearly profitable; the margin trajectory is stable-to-improving, which supports the thesis that KLA's process-control monopoly commands durable pricing power even as the cycle matures.
Balance-sheet health is solid but not fortress-like: the current ratio of 2.88 and quick ratio of 2.03 indicate ample liquidity, while debt-to-equity of 0.969 is moderate for a capital-equipment firm and interest coverage of 21.2x reflects comfortable debt service. Free cash flow was $817 million in the June quarter (down from $1.26 billion in December), and TTM FCF of $3.77 billion against a $395.7 billion market cap implies a thin FCF yield of roughly 0.95% — a valuation that leaves little cushion. ROE of 76.08% is extraordinary, driven by a high equity multiplier (2.83x) and aggressive buybacks ($571 million repurchased in the June quarter alone), but the cash flow coverage ratio of 0.147 and cash conversion cycle of 264 days (with 232 days of inventory outstanding) highlight working-capital intensity that could pressure FCF if the cycle turns.
Quarterly Revenue
$3.7B
2026-06
Revenue YoY Growth
+15.2%
YoY Comparison
Gross Margin
61.4%
Latest Quarter
Free Cash Flow
$3.8B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is KLAC Overvalued?
Because KLA is solidly profitable (net income of $1.363 billion in the latest quarter), the PE ratio is the appropriate primary metric: the trailing PE of 81.99x is extreme, but the forward PE of 24.59x — based on consensus FY EPS of $10.15 — implies the market expects earnings to roughly triple, a gap that signals either enormous expected growth or a trailing figure distorted by the ten-for-one split and one-time items. The PEG ratio of 3.99 and EV/EBITDA of 66.10x confirm the stock is priced for perfection; the forward multiple of 24.6x is far more reasonable and suggests the market is looking through near-term noise to a normalized earnings base.
Relative to the semiconductor equipment peer group, KLA trades at a steep premium: its PS ratio of 29.14x and EV/Sales of 16.88x are multiples typically reserved for hyper-growth software, while the 61.3% gross margin and 35.6% net margin justify part of the premium versus the broader sector's mid-teens margins. The PB ratio of 62.32x is an outlier even for asset-light equipment makers, reflecting the buyback-driven shrinkage of book equity rather than operational leverage; the 3.99 PEG and 66.1x EV/EBITDA suggest the premium is stretched relative to growth, and the 0.27% dividend yield offers negligible income support.
Historically, KLA's valuation has expanded dramatically: the PE ratio has risen from 24.58x in June 2025 to 81.99x now, and the PS ratio has climbed from 37.25x to 108.19x over the same period — placing the stock at the very top of its own multi-year valuation band. The PB ratio of 62.32x versus 25.20x a year ago and 20.46x in late 2022 shows the market has repriced KLA as an AI-scarcity asset, but the current levels embed optimistic assumptions that leave little margin of safety; a reversion toward the 25–35x PE range seen through 2024–2025 would imply substantial downside from current levels.
PE
82.0x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 10x~40x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
66.1x
Enterprise Value Multiple
Investment Risk Disclosure
KLA's financial risks center on working-capital intensity and a thin free-cash-flow yield. The cash conversion cycle of 264 days, including 232 days of inventory outstanding, ties up significant capital and could pressure FCF if the cycle turns; FCF was $817 million in the June quarter, down from $1.26 billion in December. TTM FCF of $3.77 billion against a $395.7 billion market cap implies a FCF yield of roughly 0.95%, leaving little cushion if growth slows. Debt-to-equity of 0.969 is moderate, but interest coverage of 21.2x and a current ratio of 2.88 provide adequate liquidity. The EBITDA margin dip to 32.71% in the June quarter from 46.45% in March, driven by a $196.8 million depreciation/amortization swing, highlights earnings volatility even at stable gross margins.
Market and competitive risks are elevated by the stock's premium valuation and high beta. The trailing PE of 81.99x, PS of 29.14x, and EV/EBITDA of 66.10x are at the top of KLA's historical range, and a reversion toward the 25-35x PE band seen in 2024-2025 would imply substantial downside. With a beta of 1.447, KLAC is roughly 45% more volatile than the S&P 500, amplifying sector rotation risk; the -24.79 three-month relative strength versus SPY already reflects institutional distribution. Competitive threats include emerging process-control entrants and customer concentration in TSMC and Samsung, while the AI capex narrative that drove the stock to $307.37 could reverse if hyperscaler spending decelerates.
Worst-case scenario: a WFE cycle downturn combines with multiple compression, pushing the stock toward its 52-week low of $107.20, which is 35.3% below the current $165.74. This would require both earnings estimates to be cut and the forward PE to contract toward the low end of its historical range, a plausible outcome if AI capex disappoints. The max drawdown of -45.07% over the period shows such a decline is within historical experience. From the current price, an investor could lose roughly 35% to the 52-week low, and a retest of the June high would require an 85% gain, underscoring the asymmetric risk-reward at this juncture.
FAQ
The most severe risk is a WFE cycle downturn that cuts earnings estimates and compresses the multiple, potentially driving the stock toward its 52-week low of $107.20 (a 35% decline). Second is valuation compression: the trailing PE of 81.99x and PS of 29.14x are at historical extremes, and a reversion to the 25-35x PE range would imply substantial downside. Third is customer concentration, with TSMC and Samsung among the largest customers; delays in their fab expansions would directly hit KLA's orders. Fourth is competitive encroachment in process control, though KLA's majority share and 61% gross margins provide a buffer. The high beta of 1.447 amplifies all these risks in a market downturn.
The 12-month forecast has three scenarios: a base case (50% probability) targeting $200-$250 as the stock re-rates toward the analyst average of $232.77, assuming mid-teens revenue growth and EPS near $10.15; a bull case (25%) targeting $280-$325 if AI-driven orders accelerate and the multiple expands toward the high target; and a bear case (25%) targeting $107-$175 if a WFE downturn cuts estimates and compresses the multiple. The most likely scenario is the base case, which assumes the AI capex cycle remains durable but does not re-accelerate, and that KLA's forward valuation of 24.6x provides a floor. Key to the forecast is whether revenue growth holds above 15% and gross margins stay above 60%.
KLAC is overvalued on trailing metrics but fairly valued on forward earnings. The trailing PE of 81.99x, PS of 29.14x, EV/EBITDA of 66.10x, and PB of 62.32x are at the top of the stock's multi-year range, well above the 25-35x PE band seen in 2024-2025. However, the forward PE of 24.59x based on consensus EPS of $10.15 is more reasonable, and at the current price the stock trades at just 16.3x forward earnings, below the 24.6x implied by the data. The market appears to be pricing in a normalization of earnings and a durable AI-driven cycle; if that assumption holds, the stock is fairly valued to slightly undervalued, but if estimates are cut, the trailing multiples offer little support.
From a risk/reward perspective, KLAC is a reasonable buy for long-term investors but not a compelling one at current levels. The stock trades at $165.74, below the lowest analyst target of $175, with a consensus Buy rating and an average target of $232.77 implying 40.4% upside. However, the trailing PE of 81.99x and PS of 29.14x are extreme, and the -24.79 three-month relative underperformance versus the S&P 500 signals institutional selling that may not be finished. The biggest downside risk is a WFE cycle downturn that could take the stock to its 52-week low of $107.20, a 35% decline. It is a good buy for investors with a 2-3 year horizon who can tolerate volatility and believe the AI capex cycle is durable; for short-term traders, the downtrend argues for waiting for stabilization above $168.
KLAC is better suited for long-term investment (minimum 2-3 years) than short-term trading. The stock is in a confirmed intermediate downtrend, down 22.10% over three months with a -24.79 relative strength versus the S&P 500, and the 5.00% single-day drop on October 16 shows momentum is still negative. The high beta of 1.447 and -45.07% max drawdown mean short-term trading requires tight stop discipline and is exposed to sharp reversals. For long-term investors, the process-control monopoly, 61% gross margins, $1.60 billion service annuity, and 24.6x forward PE offer a reasonable entry point for a multi-year hold, but position sizing should be moderate given the volatility. A suggested minimum holding period is 2-3 years to ride out the WFE cycle.